A decade of progress in status epilepticus 2007‐2017: Proceedings of the 6th London‐Innsbruck Colloquium on Status Epilepticus and Acute Seizures Epilepsia, Volume 59, Issue S2, Page 67-69, October 2018. Seguir leyendo → 14 OCT 0
Intravenous ketamine in status epilepticus Epilepsia, Volume 59, Issue S2, Page 198-206, October 2018. Seguir leyendo → 14 OCT 0
Place of neurosteroids in the treatment of status epilepticus Epilepsia, Volume 59, Issue S2, Page 216-219, October 2018. Seguir leyendo → 14 OCT 0
Mechanisms of status epilepticus: α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor hypothesis Epilepsia, Volume 59, Issue S2, Page 78-81, October 2018. Seguir leyendo → 14 OCT 0
Treatment gap for convulsive status epilepticus in resource‐poor countries Epilepsia, Volume 59, Issue S2, Page 135-139, October 2018. Seguir leyendo → 14 OCT 0
Mitochondrial diseases and status epilepticus Epilepsia, Volume 59, Issue S2, Page 70-77, October 2018. Seguir leyendo → 14 OCT 0
Parenteral phenobarbital in status epilepticus revisited: Mayo Clinic experience Epilepsia, Volume 59, Issue S2, Page 193-197, October 2018. Seguir leyendo → 14 OCT 0
Risk score predictive of mortality in status epilepticus according to a national database Epilepsia, Volume 59, Issue S2, Page 182-187, October 2018. Seguir leyendo → 14 OCT 0
Acute and long‐term consequences of exposure to organophosphate nerve agents in humans Epilepsia, Volume 59, Issue S2, Page 92-99, October 2018. Seguir leyendo → 14 OCT 0
Neurotrophic factors and status epilepticus Epilepsia, Volume 59, Issue S2, Page 87-91, October 2018. Seguir leyendo → 14 OCT 0
